Figure 4.
Costs per cycle and cumulative costs for first- and second-line daratumumab. Costs per Markov cycle (3 months) and cumulative costs over 10 years for the (A-B) GRIFFIN model and (C-D) CASSIOPEIA model.
Costs per cycle and cumulative costs for first- and second-line daratumumab. Costs per Markov cycle (3 months) and cumulative costs over 10 years for the (A-B) GRIFFIN model and (C-D) CASSIOPEIA model.